192 related articles for article (PubMed ID: 8144581)
1. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide.
Schmidt AM; Mora R; Cao R; Yan SD; Brett J; Ramakrishnan R; Tsang TC; Simionescu M; Stern D
J Biol Chem; 1994 Apr; 269(13):9882-8. PubMed ID: 8144581
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.
Yan SD; Schmidt AM; Anderson GM; Zhang J; Brett J; Zou YS; Pinsky D; Stern D
J Biol Chem; 1994 Apr; 269(13):9889-97. PubMed ID: 8144582
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
Schmidt AM; Yan SD; Brett J; Mora R; Nowygrod R; Stern D
J Clin Invest; 1993 May; 91(5):2155-68. PubMed ID: 8387541
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.
Schmidt AM; Hasu M; Popov D; Zhang JH; Chen J; Yan SD; Brett J; Cao R; Kuwabara K; Costache G
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8807-11. PubMed ID: 8090728
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
Schmidt AM; Vianna M; Gerlach M; Brett J; Ryan J; Kao J; Esposito C; Hegarty H; Hurley W; Clauss M
J Biol Chem; 1992 Jul; 267(21):14987-97. PubMed ID: 1321822
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper M; Schmidt AM; Brett J; Yan SD; Wang F; Pan YC; Elliston K; Stern D; Shaw A
J Biol Chem; 1992 Jul; 267(21):14998-5004. PubMed ID: 1378843
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
8. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.
Vlassara H; Li YM; Imani F; Wojciechowicz D; Yang Z; Liu FT; Cerami A
Mol Med; 1995 Sep; 1(6):634-46. PubMed ID: 8529130
[TBL] [Abstract][Full Text] [Related]
9. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
11. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
[TBL] [Abstract][Full Text] [Related]
12. RAGE: a novel cellular receptor for advanced glycation end products.
Schmidt AM; Hori O; Cao R; Yan SD; Brett J; Wautier JL; Ogawa S; Kuwabara K; Matsumoto M; Stern D
Diabetes; 1996 Jul; 45 Suppl 3():S77-80. PubMed ID: 8674899
[TBL] [Abstract][Full Text] [Related]
13. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
14. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.
Bierhaus A; Illmer T; Kasper M; Luther T; Quehenberger P; Tritschler H; Wahl P; Ziegler R; Müller M; Nawroth PP
Circulation; 1997 Oct; 96(7):2262-71. PubMed ID: 9337199
[TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of a CA(2+)-dependent lactoferrin receptor in rat liver. Lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent manner.
McAbee DD; Bennatt DJ; Ling YY
Adv Exp Med Biol; 1998; 443():113-21. PubMed ID: 9781350
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells.
Tanaka N; Yonekura H; Yamagishi S; Fujimori H; Yamamoto Y; Yamamoto H
J Biol Chem; 2000 Aug; 275(33):25781-90. PubMed ID: 10829018
[TBL] [Abstract][Full Text] [Related]
18. Receptors for advance glycation end-products (AGE) - expression by endothelial cells in non-diabetic uraemic patients.
Greten J; Kreis I; Wiesel K; Stier E; Schmidt AM; Stern DM; Ritz E; Waldherr R; Nawroth PP
Nephrol Dial Transplant; 1996 May; 11(5):786-90. PubMed ID: 8671895
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
